Fever News and Research

RSS

Antihistamine drugs work by preventing histamine from attaching to H1 receptors

Itchy eyes, scratchy throat, running nose--it's allergy season! What triggers these allergic reactions, and how do allergy medications work?

26 Apr 2013

Researchers call H7N9 bird flu strain 'one of the most lethal'; first case outside China reported by Taiwan

Chinese scientists have confirmed for the first time that a new strain of bird flu that has killed 23 people in China has been transmitted to humans from chickens.

26 Apr 2013

H7N9 flu virus found to transmit from birds to humans but not person-to-person

Scientists in China have confirmed for the first time that the influenza A H7N9 virus has transmitted from birds—specifically, chicken at a wet poultry market—to humans, according to an Article published Online First in The Lancet.

25 Apr 2013

Vertex presents data of telaprevir Phase 3b CONCISE study in people with genotype 1 chronic HCV

Vertex Pharmaceuticals Incorporated today announced new data from an interim analysis of the exploratory global Phase 3b CONCISE study evaluating the potential to shorten total treatment with telaprevir combination therapy to 12 weeks in certain people with genotype 1 chronic hepatitis C virus infection who have the IL28B CC genotype.

25 Apr 2013

Research maps risk factors for transmission of animal brucellosis, BTB to humans

A new study at the Institute of Tropical Medicine in Antwerp analyses the impact of animal brucellosis and bovine tuberculosis on animals and people in urban, peri-urban and rural Niger.

24 Apr 2013

Study: Nearly two-thirds of children receiving stem cell transplants return to hospital within six months

Nearly two-thirds of children receiving stem cell transplants returned to the hospital within six months for treatment of unexplained fevers, infections or other problems, according to a study performed at Dana-Farber/Children's Hospital Cancer Center in Boston.

24 Apr 2013

Janssen announces safety results from two Phase 3 studies of simeprevir in hepatitis C patients

Janssen R&D Ireland today announced primary efficacy and safety results from two global Phase 3 studies demonstrating that use of the investigational protease inhibitor simeprevir (TMC435) led to sustained virologic response 12 weeks after the end of treatment (SVR12) in 80 and 81 percent, respectively, of treatment-naive genotype 1 chronic hepatitis C adult patients with compensated liver disease, including all stages of liver fibrosis, when administered once daily with pegylated interferon and ribavirin.

24 Apr 2013

Clinical data on simeprevir for treatment of hepatitis C patients to be presented at EASL meeting

Medivir AB today announces that data will be presented on the investigational protease inhibitor simeprevir (TMC435) for the treatment of genotype 1 hepatitis C patients.

23 Apr 2013

Nuvo Research reaches another milestone with the launch of Pliaglis in Europe

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and Galderma Pharma, S.A., today announced the European launch of Pliaglis (lidocaine and tetracaine) Cream 7%/7%.

23 Apr 2013

ViroPharma announces results of VP20621 Phase 2 study for preventing recurrent CDI

ViroPharma Incorporated, an international biopharmaceutical company committed to developing and commercializing innovative products that address unmet medical needs and rare diseases, today announced the results of a Phase 2 study of VP20621 (non-toxigenic Clostridium difficile; NTCD) a novel treatment approach for preventing recurrent C. difficile infections.

23 Apr 2013

Romark Laboratories starts NT-300 Phase 3 trial for treatment of acute uncomplicated influenza

Romark Laboratories announced that it has begun enrolling patients in a global Phase 3 clinical trial of NT-300 (nitazoxanide) for treatment of acute uncomplicated influenza.

19 Apr 2013

Pediatric allergist offers tips to protect kids from allergies during the spring

Spring is having a hard time deciding if it wants to be here this year. Still, for many allergy sufferers its presence is being felt. Allergies are extremely common with an estimated 50 million people in the United States suffering from them.

19 Apr 2013

Scientists working on pollen count map to warn hay fever sufferers

In future there could be precise, personal travel warnings for hay fever sufferers covering the whole of Europe. The pollen warning service of the MedUni Vienna is working on a pollen count map in order to be better able to warn hay fever sufferers.

18 Apr 2013

ACAAI to offer free screenings for allergies and asthma

More than 50 million Americans suffer from allergies and asthma, a number that continues to rise annually. To help children and adults with symptoms of these conditions know if they are at risk, allergists from around the country will conduct the 17th annual Nationwide Asthma Screening Program.

16 Apr 2013

New data on T cells' protective role suggests need for new approach to dengue vaccine design

As efforts to create a strong and effective vaccine for the dreaded dengue virus continue to hit snags, a new study from researchers at the La Jolla Institute for Allergy & Immunology offers surprising evidence that suggests the need for a revamped approach to dengue vaccine design.

15 Apr 2013

Australian, Singapore researchers join hands to combat disease-causing bugs

The fight against a number of significant infectious diseases in the Asia-Pacific region has been given a boost through a new research collaboration between the National Health and Medical Research Council in Australia and the Agency for Science, Technology and Research in Singapore.

12 Apr 2013

Rising temperature induces key changes in dengue virus

Researchers have discovered that rising temperature induces key changes in the dengue virus when it enters its human host, and the findings represent a new approach for designing vaccines against the aggressive mosquito-borne pathogen.

12 Apr 2013

New tool to identify air travelers with infectious disease developed

Researchers have developed a simple new tool to help governments worldwide decide whether to screen airplane passengers leaving or arriving from areas of infectious disease outbreaks.

11 Apr 2013

FDA accepts Merck's NDA for NOXAFIL tablets

Merck, known as MSD outside the United States and Canada, today announced that its New Drug Application for an investigational, tablet formulation of the company's antifungal agent, NOXAFIL (posaconazole), has been accepted for review by the U.S. Food and Drug Administration.

11 Apr 2013

Scientists reveal new technique to introduce disease-blocking bacteria into mosquitoes

Scientists have revealed a new technique to introduce disease-blocking bacteria into mosquitoes, with promising results that may halt the spread of diseases such as dengue, yellow fever and potentially malaria.

11 Apr 2013

Fever News and Research

Antihistamine drugs work by preventing histamine from attaching to H1 receptors

Researchers call H7N9 bird flu strain 'one of the most lethal'; first case outside China reported by Taiwan

H7N9 flu virus found to transmit from birds to humans but not person-to-person

Vertex presents data of telaprevir Phase 3b CONCISE study in people with genotype 1 chronic HCV

Research maps risk factors for transmission of animal brucellosis, BTB to humans

Study: Nearly two-thirds of children receiving stem cell transplants return to hospital within six months

Janssen announces safety results from two Phase 3 studies of simeprevir in hepatitis C patients

Clinical data on simeprevir for treatment of hepatitis C patients to be presented at EASL meeting

Nuvo Research reaches another milestone with the launch of Pliaglis in Europe

ViroPharma announces results of VP20621 Phase 2 study for preventing recurrent CDI

Romark Laboratories starts NT-300 Phase 3 trial for treatment of acute uncomplicated influenza

Pediatric allergist offers tips to protect kids from allergies during the spring

Scientists working on pollen count map to warn hay fever sufferers

ACAAI to offer free screenings for allergies and asthma

New data on T cells' protective role suggests need for new approach to dengue vaccine design

Australian, Singapore researchers join hands to combat disease-causing bugs

Rising temperature induces key changes in dengue virus

New tool to identify air travelers with infectious disease developed

FDA accepts Merck's NDA for NOXAFIL tablets

Scientists reveal new technique to introduce disease-blocking bacteria into mosquitoes

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News